Patient study for the treatment of rheumatoid arthritis

Are you

• a patient with rheumatoid arthritis who, despite receiving a stable dose of medication for at least 12 weeks prior to the screening visit, still experiences symptoms but is otherwise in good general health
• a man or woman
• between 18 and 75 years (inclusive)
• with a BMI between 18 and 35 kg/m² (inclusive)
  • with a minimum weight of 50 kg
• who does not smoke or smokes a maximum of 10 cigarettes per day (smoking is not permitted during your stay)

What does this trial involve?

in study 2600007 part 2, SGS CPU is investigating the treatment of rheumatoid arthritis. During +/- 20 weeks you will have the following appointments:

• a screening visit
• a stay of 4 days (3 nights)
• 7 morning return visits
• 1 (or 2) end of trial visit(s)

Take part in this trial and

• contribute to the medicine of tomorrow
• a compensation* will be provided

*including travel expenses

This study was approved by the competent Belgian health authorities and an independent ethics committee.

View information leaflet

View study dates